0000950170-24-046095.txt : 20240419
0000950170-24-046095.hdr.sgml : 20240419
20240419170815
ACCESSION NUMBER: 0000950170-24-046095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240417
FILED AS OF DATE: 20240419
DATE AS OF CHANGE: 20240419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Esser Eric Eugene
CENTRAL INDEX KEY: 0001933819
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40497
FILM NUMBER: 24858778
MAIL ADDRESS:
STREET 1: C/O CODEX DNA, INC.
STREET 2: 9535 WAPLES STREET, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Telesis Bio Inc.
CENTRAL INDEX KEY: 0001850079
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 451216839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10431 WATERIDGE CIRCLE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-228-4115
MAIL ADDRESS:
STREET 1: 10431 WATERIDGE CIRCLE
STREET 2: SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Codex DNA, Inc.
DATE OF NAME CHANGE: 20210309
4
1
ownership.xml
4
X0508
4
2024-04-17
0001850079
Telesis Bio Inc.
TBIO
0001933819
Esser Eric Eugene
C/O TELESIS BIO INC.
10431 WATERIDGE CIRCLE, SUITE 150
SAN DIEGO
CA
92121
true
true
false
false
President & CEO
false
Common Stock
2024-04-17
4
A
false
100000
0
A
129260
D
Stock Option (right to buy)
0.38
2024-04-17
4
A
false
200000
0
A
2034-04-17
Common Stock
200000
200000
D
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 50% of the RSUs shall vest on April 17, 2025, and the remaining 50% of the RSUs shall vest on April 17, 2026.
Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, 25% of the shares subject to the option shall vest on April 17, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
/s/ Rob Cutler, as Attorney-in-Fact
2024-04-19